<DOC>
	<DOCNO>NCT00233558</DOCNO>
	<brief_summary>The purpose study evaluate clinical efficacy schedule versus free reduction steroid treatment patient active RA treat adalimumab + MTX</brief_summary>
	<brief_title>Open-Label Steroid Reduction Study Adalimumab With Methotrexate Patients With Active Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Subject age 18 old good health ( Investigator discretion ) recent stable medical history Subject diagnosis rheumatoid arthritis define 1987revised ACR criterion Subject consider investigator , reason , unsuitable candidate study Female subject pregnant breastfeeding consider become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>